Blank check company Therapeutics Acquisition Corp. (TXACU) (TXAC) has filed a preliminary prospectus for a $100M IPO.
The company plans to offer 10M units at $10 per
unit, each consisting of one Class A common share and 1/3rd of a
redeemable five-year warrant to purchase one Class A share at $11.50.
Its sponsor is life sciences investment firm RA
Capital, which has over $4B under management. The focus will be the U.S.
healthcare sector.
https://seekingalpha.com/news/3583315-therapeutics-acquisition-corp-readies-ipo
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.